ARTBIO · 5 months ago
Senior Medical Director, Clinical Development
ARTBIO is a global biotech company redefining cancer care through innovative radioligand therapies. The Senior Medical Director will provide clinical leadership for Phase 1-3 studies, collaborate with various teams, and ensure the successful execution of clinical goals and objectives.
BiotechnologyHealth CareHospitalMedicalMedical DevicePharmaceutical
Responsibilities
Primary responsibility for clinical and safety oversight of company sponsored Phase 0-3 clinical trials
Key clinical expert for study protocols and clinical development plans for each molecule in clinical development
Key clinical stakeholder to answer health authority and IRB/ethics committee questions for the molecules in clinical development
Works with medical writing and regulatory, and clinical operations to author protocols, investigator brochures, annual reports, clinical study reports and DSURs
Leads and when necessary supports clinical study start-up, data base locks, and study closeouts
Primary medical reviewer for ongoing and active company-sponsored studies
Collaborate with cross functional partners to execute on clinical goals and objectives, ensuring timely achievement of milestones
Lead clinical study teams, ensuring effective communication and coordination in partnership with the clinical operations team
Provide strategic input to potential partnership and licensing opportunities
Maintain the highest standards of clinical study and operational integrity
Qualification
Required
MD or equivalent degree with postdoctoral training in an oncology specialty
Minimum of 4 years of relevant clinical research experience for therapeutic molecules in a relevant academic setting or in the biotech/pharma industry
Preferred
RLT experience is nice but not mandatory
Company
ARTBIO
ARTBIO is a clinical-stage radiopharmaceutical biotechnology business that is working to create a new class of alpha radioligand medicines.
Funding
Current Stage
Growth StageTotal Funding
$245MKey Investors
Third Rock VenturesF-Prime
2025-07-29Series B· $132M
2023-12-07Series A· $90M
2023-06-21Seed· $23M
Recent News
2026-01-06
Morningstar.com
2025-09-09
Company data provided by crunchbase